Longevity Today
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
Sign In
Deep Dive Audio
Mitochondrial Peptide MOTS-c Shields Lungs From Reperfusion Injury via Novel Nuclear PathwayLongevity & Aging

Mitochondrial Peptide MOTS-c Shields Lungs From Reperfusion Injury via Novel Nuclear Pathway

Researchers discovered that MOTS-c, a 16-amino acid peptide encoded in mitochondrial DNA, protects lung endothelial cells during ischemia-reperfusion injury by translocating into the nucleus via a MYH9-dependent mechanism. During oxidative stress, reactive oxygen species activate the kinase CK2A, which phosphorylates MYH9 at Ser1943, enabling MOTS-c to bind the MYH9-γ-actin complex and travel to the nucleus. Once there, MOTS-c directly activates antioxidant genes like HMOX1 and NQO1 via antioxidant response elements. In 150 cardiac surgery patients, rising serum MOTS-c levels over 24 hours post-bypass (ΔMOTS-c) predicted ARDS with an AUC of 0.885. Exogenous MOTS-c administration in rat models reduced lung damage, inflammation, and mortality.

Deep Dive Audio
0:00--:--
Read Full Article
Longevity Today

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

© 2026 Longevity Today. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Today is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.